HOOPER, LUNDY & BOOKMAN, P.C. lobbying for BRAINFUTURES

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

LISA LAYMAN New on this filing

Previously held: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

S 331
HALT Fentanyl Act

Lobbying activity 2

Health Issues

Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.

Medical/Disease Research/Clinical Labs

Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.